Maxycon Pharmaceutical Private Limited
About Maxycon Pharmaceutical Private Limited
Data last updated:
Maxycon Pharmaceutical Private Limited was a private limited company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 June 2008.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PTC179826.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Dev Muni Upadhyay and Vandana Gupta.
Its last annual general meeting (AGM) was held on 29 September 2009, and its latest financial statements are for the year ended 31 March 2009. The registered office was at 3343A First Floor Mahindra Park Above Hyundai Service Station Rani Bagh, Delhi, India – 110034.
Company details
Contact details
Maxycon Pharmaceutical Private Limited's registered office is in Delhi, Delhi.
- Registered Address3343A First Floor Mahindra Park Above Hyundai Service Station Rani Bagh, Delhi, India – 110034
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Maxycon Pharmaceutical Private Limited
FY 2009 filings availableFinancial Statement Summary
| Metrics | FY 2008-09 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2008-09 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Maxycon Pharmaceutical Private Limited, buy the company report.
Board of directors of Maxycon Pharmaceutical Private Limited
Maxycon Pharmaceutical has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dev Muni Upadhyay Also directs: Long Life Pharmaceuticals Private Limited | Director | 11 May 2009 | 17 Years 5 Months | As last reported |
| Vandana Gupta | Director | 03 May 2011 | 15 Years 5 Months | As last reported |
| Neeta Gupta | Director | 03 May 2011 | 15 Years 5 Months | As last reported |
| Anshul Gupta | Director | 03 May 2011 | 15 Years 5 Months | As last reported |
| Mohan Ram | Director | 20 Jun 2008 | 18 Years 4 Months | As last reported |
Legal cases
No court or tribunal cases involving Maxycon Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxycon Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Maxycon Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Maxycon Pharmaceutical Private Limited has 11 board changes on record since 2008: 5 appointments and 6 cessations. The latest: Dev Muni Upadhyay ceased to be Director on 04 Apr 2017.
2 earlier events are in the company report.
Frequently asked questions
Maxycon Pharmaceutical has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Maxycon Pharmaceutical was a private limited company based in Delhi, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 June 2008 and is registered under CIN U24232DL2008PTC179826. The company has been struck off by the Registrar of Companies and is no longer operational.
Maxycon Pharmaceutical had 5 directors:
- Dev Muni Upadhyay - Director
- Vandana Gupta - Director
- Neeta Gupta - Director
- Anshul Gupta - Director
- Mohan Ram - Director
The CIN (Corporate Identification Number) of Maxycon Pharmaceutical is U24232DL2008PTC179826. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Maxycon Pharmaceutical is at 3343A First Floor Mahindra Park Above Hyundai Service Station Rani Bagh, Delhi, India – 110034.
Maxycon Pharmaceutical was incorporated on 20 June 2008. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Maxycon Pharmaceutical on record with the MCA are for the year ended 31 March 2009. Its last annual general meeting was held on 29 September 2009. Year-wise statements from 2015 are in the company report.
Maxycon Pharmaceutical operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.
Dev Muni Upadhyay ceased to be Director on 04 Apr 2017. Anshul Gupta was appointed as Director on 03 May 2011. Hargovind Singh Bisht ceased to be Director on 03 May 2011. Maxycon Pharmaceutical has 11 board changes on record in total.
Maxycon Pharmaceutical can be reached at its registered office: 3343A First Floor Mahindra Park Above Hyundai Service Station Rani Bagh, Delhi, India – 110034.